The FDA Is About to Decide the Future of Peptides: BPC-157, TB-500, KPV, & MOTS-C
This Is Not Covered — Dr. Ashley Froese — The FDA Is About to Decide the Future of Peptides: BPC-157, TB-500, KPV, & MOTS-C
Channel: This Is Not Covered - Dr. Ashley Froese · Our label: Clinician educator · Source: youtube.com/watch?v=CH6wz3qEGgM
What this video covers
On July 23rd and 24th, the FDA is hosting a special council to decide the legal fate of seven of the most popular peptides. If you use or know about BPC157, TB500, together known as the Wolverine blend, or the more recently popular Mott C, and have noticed the power of these peptides, they might be more prescribable soon. What will this do to the gray market for peptides? Because this meeting isn’t deciding whether these peptides work.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- On July 23rd and 24th, the FDA is hosting a special council to decide the legal fate of seven of the most popular peptides.
- It’s deciding whether the evidence for specific medical uses is strong enough for compoundingies to legally compound them.
- Now, the committee is going to weigh scientific data on each compound to determine whether the clinical evidence justifies recommending each compound for specifically nominated therapeutic indications or diseases or treatments.
- And importantly, after this, if a compound is approved, doctors will retain the right to practice medicine and use the compounds for those indications or however they see fit.
- So, a doctor can still prescribe BPC 157 for a torn tendon or arthritis off label, even if the FDA only reviews it for gut health.
- But KPV is also being evaluated on July 23rd for wound healing and inflammatory conditions, which surprised me because there’s some great research on KPV in animals and inflammatory bowel disease, which ulcerative colitis is.
Read next
- BPC-157 — compound page
- TB-500 — compound page
- MOTS-c — compound page
- KPV — compound page
- Wolverine stack
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.